[Therapeutic angiogenesis awakens hope. New blood vessels for arterial occlusive disease patients? (interview by Dr. Judith Neumaier)].
Diehm
Curt
C
D001157:Arterial Occlusive Diseases / Q000628:therapy*; D016228:Endothelial Growth Factors / Q000008:administration & dosage* / Q000235:genetics; D005346:Fibroblast Growth Factors / Q000008:administration & dosage* / Q000235:genetics; D015316:Genetic Therapy; D006801:Humans; D007866:Leg / Q000098:blood supply*; D008222:Lymphokines / Q000008:administration & dosage* / Q000235:genetics; D018919:Neovascularization, Physiologic / Q000187:drug effects*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors
D016228:Endothelial Growth Factors; D008222:Lymphokines; D011994:Recombinant Proteins; D042461:Vascular Endothelial Growth Factor A; D042442:Vascular Endothelial Growth Factors; D005346:Fibroblast Growth Factors